Health products policy and standards
Our team provides authoritative guidance and standards on quality, safety and efficacy of health products and supports countries to formulate evidence-based policies and ensure good practice throughout the value chain.
/health-product-policy-and-standards-(hps)/63022.jpg?sfvrsn=e93c78d1_9 "Ministry of Health staff at their office in Port Vila")
/health-product-policy-and-standards-(hps)/who_034416-sm.jpg?sfvrsn=fc08f9ca_4 "WHO_034416 sm")
/health-product-policy-and-standards-(hps)/70820.jpg?sfvrsn=6b0fda4c_1 "70820")
Expert Committees
Advisory groups
Databases
Publications
All →
12 February 2026
The selection and use of essential medicines: report of the WHO Expert Committee on Selection and Use...
The 25th meeting of the WHO Expert Committee on Selection and Use of Essential Medicines was held in Geneva, Switzerland, from 5 to 9 May 2025. The Committee...
11 February 2026
Blended learning platform for primary health care and community level workers: user guide to Learning...
Learning on TAP (TAP for short) is a blended learning resource developed by WHO and is part of the WHO Academy: https://whoacademy.org/TAP/. TAP is an...
30 January 2026
WHO Drug Information - Volume 39, No. 4
The Fourth issue of volume 39 for 2025 includes:Pharmaceutical News- Thin-Layer Chromatography: A Valuable Tool in the Fight Against Substandard/Falsified...
1 December 2025
Assistive technology progress assessment questionnaire: tracking progress on access to assistive technology
In May 2018, the World Health Assembly (WHA) adopted resolution WHA71.8 on improving access to assistive technology. The resolution urges Member States...
Journal articles
Intradermal Administration of Fractional Doses of Inactivated Poliovirus Vaccine: A Dose-Sparing Option for Polio Immunization
The Journal of Infectious Diseases, 01 Jul 2017, 216(suppl_1):S161-S167
Cessation of Trivalent Oral Poliovirus Vaccine and Introduction of Inactivated Poliovirus Vaccine - Worldwide, 2016
MMWR Morbidity and Mortality Weekly Report. 2016 Sep 9;65(35):934-8.
Cost-effectiveness analysis of typhoid conjugate vaccines in five endemic low- and middle-income settings
Vaccine, Volume 35, Issue 27, 14 June 2017, Pages 3506-3514
/health-product-policy-and-standards-(hps)/access-to-assistive-technology-and-medical-devices-(atm)/046a0259.tmb-549v.jpg?sfvrsn=12543565_2)
